https://www.selleckchem.com/pr....oducts/hsp990-nvp-hs
Perampanel is a highly selective and non-competitive α-amino-3-hydroxy-5 -methyl-4-isoxazole propionate (AMPA) receptor (AMPAR) antagonist, which has been licensed as an orally administered antiepileptic drug in more than 55 countries. Recently, perampanel was found to exert neuroprotective effects in hemorrhagic and ischemic stroke models. In this study, the protective effect of perampanel was investigated. The protective effect of perampanel was investigated in an in vitro traumatic neuronal injury (TNI) model in primary cul
Like
Comment
Share
